Eric Hsu
Eric Hsu is a Director, Alliance Management at Samsung Biologics, focused on expanding relationships with the company’s key strategic partners. He has over 14 years of experience in the healthcare industry across varying roles, including alliance management, sales, market intelligence, and regulatory. Prior to joining Samsung Biologics, Eric worked at Pfizer and in healthcare consulting. He earned an MSE in Bioengineering from the University of Pennsylvania and a BS in Bioengineering from Lehigh University.
Company:Samsung Biologics
Samsung Biologics is a fully integrated CDMO offering state-of-the-art contract development and manufacturing services. With proven regulatory approvals, the largest capacity, and the fastest throughput, Samsung Biologics is an award-winning partner of choice and is uniquely able to support the development and manufacturing of biologics products at every stage of the process while meeting the evolving needs of biopharmaceutical companies worldwide. For more information, visit samsungbiologics.com.
